Literature DB >> 9454765

Altered interleukin-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1.

J A Gollob1, E A Murphy, S Mahajan, C P Schnipper, J Ritz, D A Frank.   

Abstract

T-cell activation in response to interleukin-12 (IL-12) is mediated through signaling events that include the tyrosine phosphorylation of STAT4. IL-12 responsiveness and the ability of IL-12 to activate STAT4 is different in T cells induced to differentiate into a Th1 or Th2 phenotype. In this report, we show that STAT5, STAT1alpha, and STAT1beta, in addition to STAT4, are tyrosine phosphorylated in response to IL-12 in phytohemagglutinin (PHA)-activated human T cells. To understand how the activation of these STATs contributes to T-cell IL-12 responsiveness, we analyzed the IL-12-induced activation of STAT5 and STAT1 in T cells stimulated to undergo Th1 or Th2 differentiation. The IL-12-induced tyrosine phosphorylation of STAT5 and STAT1, but not STAT4, is augmented in T cells activated into Th1 cells with PHA + interferon-gamma (IFN-gamma) compared with T cells activated with PHA alone. STAT5 DNA binding induced by IL-12 is also augmented in T cells activated with PHA + IFN-gamma compared with T cells activated with PHA alone, whereas STAT4 DNA binding is not increased. In contrast, the IL-12-induced activation of these STATs is inhibited in T cells activated into Th2 cells with PHA + IL-4. The enhancement of IL-12 signaling by IFN-gamma is not a direct effect of IFN-gamma on T cells, but rather is mediated by IL-12 that is produced by antigen-presenting cells in response to IFN-gamma. This positive autoregulatory effect of IL-12 on the activation of select STATs correlates with an increase in T-cell IFN-gamma production in response to IL-12. These findings suggest that the activation of STAT5 and STAT1 may augment select STAT4-dependent functional responses to IL-12 in Th1 cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454765

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Deconvoluting global cytokine signaling networks in natural killer cells.

Authors:  Gabriela M Wiedemann; Endi K Santosa; Simon Grassmann; Sam Sheppard; Jean-Benoît Le Luduec; Nicholas M Adams; Celeste Dang; Katharine C Hsu; Joseph C Sun; Colleen M Lau
Journal:  Nat Immunol       Date:  2021-04-15       Impact factor: 25.606

Review 2.  Interleukin-35 in immune-related diseases: protection or destruction.

Authors:  Junfeng Zhang; Yunsheng Zhang; Qingpeng Wang; Chunlei Li; Hongxin Deng; Chuanping Si; Huabao Xiong
Journal:  Immunology       Date:  2019-03-07       Impact factor: 7.397

3.  Serine protease inhibition attenuates rIL-12-induced GZMA activity and proinflammatory events by modulating the Th2 profile from estrogen-treated mice.

Authors:  Ebru Karpuzoglu; Chad W Schmiedt; Julian Pardo; Megan Hansen; Tai L Guo; Steven D Holladay; Robert M Gogal
Journal:  Endocrinology       Date:  2014-05-19       Impact factor: 4.736

Review 4.  Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function.

Authors:  Esther van de Vosse; Elgin G R Lichtenauer-Kaligis; Jaap T van Dissel; Tom H M Ottenhoff
Journal:  Immunogenetics       Date:  2003-02-21       Impact factor: 2.846

5.  STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis.

Authors:  C J Godshall; A B Lentsch; J C Peyton; M J Scott; W G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

6.  Interleukin-4 supports interleukin-12-induced proliferation and interferon-gamma secretion in human activated lymphoblasts and T helper type 1 cells.

Authors:  Martin A Kriegel; Theresa Tretter; Norbert Blank; Martin Schiller; Christoph Gabler; Silke Winkler; Joachim R Kalden; Hanns-Martin Lorenz
Journal:  Immunology       Date:  2006-06-06       Impact factor: 7.397

7.  STAT4 is a critical mediator of early innate immune responses against pulmonary Klebsiella infection.

Authors:  Jane C Deng; Xianying Zeng; Michael Newstead; Thomas A Moore; Wan C Tsai; Victor J Thannickal; Theodore J Standiford
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

8.  Massive interleukin-12-induced interferon-gamma production by interleukin-15-stimulated lamina propria lymphocytes followed by down-regulation of the interleukin-12 receptor.

Authors:  Ellen C Ebert; Bana Jabri
Journal:  Immunology       Date:  2008-06-28       Impact factor: 7.397

9.  Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-γ.

Authors:  Madhuchhanda Kundu; Avik Roy; Kalipada Pahan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

10.  Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells.

Authors:  C E Verhagen; H H Smits; F A Verreck; E A Wierenga; M Kurimoto; D A Lammas; D S Kumararatne; O Sanal; F P Kroon; F Sinigaglia; T H Ottenhoff
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.